Sign In
Buy GOSS
$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
ConocoPhillips To Rally Over 30%? Here Are 10 Other Price Target Changes For Wednesday
12:46pm, Wednesday, 07'th Dec 2022 Benzinga
Barclays raised ConocoPhillips (NYSE: COP) price target from $135 to $151. Barclays analyst Jeanine Wai maintained an Overweight rating on the stock. ConocoPhillips shares fell 3.2% to close at $1
Dow Dips Over 500 Points; Nasdaq Down 2.5%
07:36pm, Tuesday, 06'th Dec 2022 Benzinga
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 2.5% on Tuesday.
The Dow traded down 1.50% to 33,436.64 while the NASDAQ fell 2.51% to 10,958.00. The S&P
Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
06:31pm, Tuesday, 06'th Dec 2022 Benzinga
Gainers
Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecif
Analyst Turns Bullish On Aerovate As Competitor Data Reinforce Lead Program Thesis
06:19pm, Tuesday, 06'th Dec 2022 Benzinga
BTIG upgraded Aerovate Therapeutics Inc (NASDAQ: AVTE) from Neutral to Buy with a price target of $27.
The analyst writes that to Aerovate's benefit, Gossamer Bio Inc's (NASDAQ: GOSS) TORREY Pha
S&P 500 Down Over 1%; Crude Oil Falls Sharply
05:05pm, Tuesday, 06'th Dec 2022 Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday.
The Dow traded down 0.74% to 33,694.46 while the NASDAQ fell 1.57% to 11,063.55. The S&P 500
Meta Platforms, Herbalife And Some Other Big Stocks Moving Lower On Tuesday
04:31pm, Tuesday, 06'th Dec 2022 Benzinga
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Tuesday. Here are some big stocks recording losses in today’s session.
Gossamer Bio, Inc. (NASDAQ: GOSS) shares tumbled 70.6
Dow Drops 100 Points; US Trade Deficit Widens In October
03:17pm, Tuesday, 06'th Dec 2022 Benzinga
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.31% to 33,842.20 while the NASDAQ fell 1.23
Gossamer Bio tumbles as hypertension drug underperforms rival product in Phase 2 trial
02:54pm, Tuesday, 06'th Dec 2022
Gossamer Bio Inc stock lost three quarters of its value today as the market questioned the performance of the company's experimental hypertension drug in a Phase 2 clinical trial despite an upbeat as
Why Is Gossamer Bio (GOSS) Stock Down Over 70% Today?
10:51am, Tuesday, 06'th Dec 2022
Gossamer Bio (NASDAQ: GOSS ) is one of the top-trending tickers on social media today, and its shares are plunging more than 70%. The company announced that a trial of its drug for hypertension, seral
Gossamer Bio's stock falls 64% on findings for Phase 2 study for hypertension drug
08:19am, Tuesday, 06'th Dec 2022
Shares of Gossamer Bio Inc. GOSS, +2.99% plunged 64.5% in premarket trading on Tuesday after Wall Street analysts questioned the performance of the company's experimental hypertension drug in a Phase
Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial
07:37pm, Thursday, 17'th Nov 2022 Benzinga
Raymond James maintains Outperform on Gossamer Bio Inc (NASDAQ: GOSS) with a price target down from $18 to $15.
The analyst expects a somewhat smaller effect size for seralutinib vs. sotatercept's
What 4 Analyst Ratings Have To Say About Gossamer Bio
04:03pm, Thursday, 17'th Nov 2022 Benzinga
Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
1
0
0
La
Analyst Ratings for Gossamer Bio
02:02pm, Thursday, 17'th Nov 2022 Benzinga
Within the last quarter, Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
1
0
0
Last 30
4 Analysts Have This to Say About Gossamer Bio
01:04pm, Thursday, 17'th Nov 2022 Benzinga
Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
1
0
0
Last 30D
What Makes Gossamer Bio (GOSS) a New Buy Stock
05:00pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Gossamer Bio (GOSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
